Pfizer unveils its oral SARS-CoV-2 inhibitor PF-07321332 which is in Phase 1 clinical trials

New Insights on Cause of Severe Reactions Following Pfizer/BioNTech mRNA COVID-19 Vaccination

Pfizer's COVID-19 vaccine effective after 6 months and works against problem variant

Pfizer says its COVID-19 vaccine has 100 percent efficacy in young people